CR20160188A - Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido - Google Patents

Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido

Info

Publication number
CR20160188A
CR20160188A CR20160188A CR20160188A CR20160188A CR 20160188 A CR20160188 A CR 20160188A CR 20160188 A CR20160188 A CR 20160188A CR 20160188 A CR20160188 A CR 20160188A CR 20160188 A CR20160188 A CR 20160188A
Authority
CR
Costa Rica
Prior art keywords
solution
solutions
organ
stability
increase
Prior art date
Application number
CR20160188A
Other languages
English (en)
Inventor
Mahendra Suryan
Original Assignee
Somahlution Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somahlution Llc filed Critical Somahlution Llc
Publication of CR20160188A publication Critical patent/CR20160188A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)

Abstract

Se divulgan soluciones de conservación de tejido y órganos que tienen mejorada establidad. Las soluciones están compuestas por dos soluciones separadas. La primera solución, Solución A, está compuesta por una solución salina balanceada que es estable en solución a un pH de 7,0 o superior. Una segunda solución, solución B, está compuesta por una solución acuosa que contiene L-glutationa y/o cisteinilglicina, un azúcar tal como D-Glucosa, L-Arginina, un agente reductor tal como ácido ascórbico y agua, a un pH inferior a 7,0, preferentemente, de alrededor de 3,0 a 5,0.
CR20160188A 2013-11-22 2016-04-22 Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido CR20160188A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361963093P 2013-11-22 2013-11-22
PCT/US2014/066054 WO2015077199A1 (en) 2013-11-22 2014-11-18 Solutons for increasing the stability and shelf life of an organ tissue preservation solution

Publications (1)

Publication Number Publication Date
CR20160188A true CR20160188A (es) 2016-07-04

Family

ID=52023642

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160188A CR20160188A (es) 2013-11-22 2016-04-22 Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido

Country Status (24)

Country Link
US (2) US11291201B2 (es)
EP (1) EP3027016B1 (es)
JP (1) JP2016537333A (es)
KR (2) KR102570322B1 (es)
CN (1) CN105916374B (es)
AR (1) AR098508A1 (es)
AU (1) AU2014353199B2 (es)
BR (1) BR112016006512B1 (es)
CA (1) CA2923441C (es)
CL (1) CL2016001003A1 (es)
CR (1) CR20160188A (es)
DK (1) DK3027016T3 (es)
EA (1) EA201691066A1 (es)
ES (1) ES2744637T3 (es)
HK (1) HK1220081A1 (es)
IL (1) IL244834B (es)
MX (1) MX2016006651A (es)
MY (1) MY181282A (es)
PE (1) PE20160861A1 (es)
PH (1) PH12016500909B1 (es)
SG (1) SG10201709595WA (es)
TW (1) TW201605342A (es)
WO (1) WO2015077199A1 (es)
ZA (1) ZA202210899B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016537333A (ja) * 2013-11-22 2016-12-01 ソマールション・エルエルシー 臓器組織保存溶液の安定性及び保存可能期間を増加させる溶液
WO2018081213A1 (en) * 2016-10-25 2018-05-03 Marquette University Storage media and powder formulations for avulsed teeth and explanted tissues comprising fibroblasts
US11980700B2 (en) 2017-03-08 2024-05-14 Alafair Biosciences, Inc. Hydrogel medium for the storage and preservation of tissue
WO2023201038A1 (en) 2022-04-15 2023-10-19 Marizyme, Inc. Powder formulations and use thereof in medical and/or surgical procedures
WO2023224887A1 (en) * 2022-05-16 2023-11-23 Marizyme, Inc. Use of cytoprotectant formulations in cell or tissue transport and/or storage
WO2024076634A1 (en) * 2022-10-04 2024-04-11 Marizyme, Inc. Kits and use thereof in surgical procedures for endoscopic harvesting of vessels

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550022A (en) 1981-10-05 1985-10-29 Alcon Laboratories, Inc. Tissue irrigating solution
US4443432A (en) 1981-10-05 1984-04-17 Alcon Laboratories, Inc. Ophthmalic irrigating solution
US5409904A (en) 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US4879283A (en) 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US4837021A (en) 1986-12-31 1989-06-06 Laboratoires P.O.S. Two part tissue irrigating solution
US5304724A (en) 1988-09-09 1994-04-19 Entravision, Inc. Tissue irrigating solution
US4938961A (en) 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia
US5257985A (en) 1989-12-04 1993-11-02 Richard Puhl Multi-chamber intravenous bag apparatus
US5066578A (en) * 1989-12-21 1991-11-19 The Regents Of The University Of California Long-term preservation of organs for transplantation
WO1992008349A1 (en) 1990-11-07 1992-05-29 Baxter International Inc. Blood platelet storage medium
DE69126861T2 (de) * 1990-11-07 1998-02-26 Baxter Int Lösung zur aufbewahrung roter blutzellen
US5498427A (en) 1990-11-20 1996-03-12 Pasteur Merieux Serums Et Vaccines Solutions for the perfusion, preservation and reperfusion of organs
EP0647398B1 (en) * 1992-06-26 1997-09-17 Torii Pharmaceutical Co., Ltd. Organ preserving fluid
BE1007500A3 (fr) 1992-09-18 1995-07-18 Pasteur Merieux Serums Vacc Solution de perfusion, de conservation et de reperfusion d'organes.
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
JP3623294B2 (ja) 1995-11-28 2005-02-23 株式会社新素材総合研究所 電解質液が収容された医療用容器及びその製造方法
US8409846B2 (en) * 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
US6153582A (en) 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
US7611830B2 (en) 2000-04-10 2009-11-03 The United States Of America As Represented By The Department Of Veteran's Affairs Device to lavage a blood vessel
US6569615B1 (en) 2000-04-10 2003-05-27 The United States Of America As Represented By The Department Of Veteran's Affairs Composition and methods for tissue preservation
SI21704A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
US20060093765A1 (en) 2004-10-29 2006-05-04 Sealed Air Corporation (Us) Multi-compartment pouch having a frangible seal
US20060160062A1 (en) 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US7575856B2 (en) 2005-10-28 2009-08-18 The United States Of America As Represented By The Department Of Veterans Affairs Compositions and methods for the evaluation and resuscitation of cadaveric hearts for transplant
EP1942726B1 (en) * 2006-04-19 2017-01-04 Transmedics, Inc. Methods for ex vivo organ care
WO2008100636A2 (en) 2007-02-17 2008-08-21 President And Fellows Of Harvard College Compositions and method for tissue preservation
US20090035240A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
JP5406049B2 (ja) * 2008-02-05 2014-02-05 協和発酵バイオ株式会社 グルタチオンの保存安定性向上方法
JP2011512351A (ja) * 2008-02-15 2011-04-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 心臓手術のための心停止液
US8608922B2 (en) 2008-11-07 2013-12-17 The University Of Connecticut Biosensor for continuous monitoring of metabolites and proteins and methods of manufacture thereof
WO2010054495A2 (en) 2008-11-14 2010-05-20 Profimed S.R.O. Non-aqueous colloidal formulation
US8288084B2 (en) 2009-07-12 2012-10-16 Revive Organtech, Inc. Composition and method for flushing and cold/cryo preserving organs, tissues, and cells
JP5752123B2 (ja) * 2009-09-01 2015-07-22 メドヴェント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング キトサン組織被覆材
FR2963965B1 (fr) 2010-08-20 2013-02-15 Vallourec Mannesmann Oil & Gas Procede et dispositif de controle d'un filetage de joint tubulaire utilise dans l'industrie du petrole
BR112015015092A2 (pt) * 2012-12-31 2017-07-11 Somahlution Llc processos para preservar a função de tecido ou órgão e para preparar formulação para preservar a mesma e kit respectivo
CN104919066A (zh) * 2013-01-09 2015-09-16 三菱综合材料株式会社 电子电气设备用铜合金、电子电气设备用铜合金薄板、电子电气设备用铜合金的制造方法、电子电气设备用导电元件及端子
WO2014176224A1 (en) 2013-04-24 2014-10-30 Somahlution, Llc Organ and tissue preservation solutions having increased oxygen-content, stability and shelf life
WO2014179113A1 (en) * 2013-04-29 2014-11-06 Somahlution, Llc Formulations containing poly (0-2-hydroxyethyl) starch for increasing the oxygen-content, stability and shelf life of an organ and tissue preservation solution
JP2016537333A (ja) * 2013-11-22 2016-12-01 ソマールション・エルエルシー 臓器組織保存溶液の安定性及び保存可能期間を増加させる溶液

Also Published As

Publication number Publication date
DK3027016T3 (da) 2019-09-16
BR112016006512B1 (pt) 2021-11-23
CA2923441C (en) 2023-03-28
CA2923441A1 (en) 2015-05-28
TW201605342A (zh) 2016-02-16
KR102428676B1 (ko) 2022-08-03
BR112016006512A2 (pt) 2017-08-01
SG10201709595WA (en) 2017-12-28
ZA202210899B (en) 2024-02-28
EP3027016A1 (en) 2016-06-08
JP2016537333A (ja) 2016-12-01
IL244834B (en) 2021-06-30
KR20160093636A (ko) 2016-08-08
MX2016006651A (es) 2016-09-06
WO2015077199A1 (en) 2015-05-28
MY181282A (en) 2020-12-21
CN105916374A (zh) 2016-08-31
AU2014353199A1 (en) 2016-04-14
EA201691066A1 (ru) 2016-09-30
US20220232822A1 (en) 2022-07-28
US11291201B2 (en) 2022-04-05
ES2744637T3 (es) 2020-02-25
PE20160861A1 (es) 2016-09-03
AR098508A1 (es) 2016-06-01
AU2014353199B2 (en) 2018-07-19
HK1220081A1 (zh) 2017-04-28
CN105916374B (zh) 2021-11-05
PH12016500909A1 (en) 2016-06-20
EP3027016B1 (en) 2019-06-12
KR20220111736A (ko) 2022-08-09
CL2016001003A1 (es) 2016-12-02
PH12016500909B1 (en) 2016-06-20
US20160249603A1 (en) 2016-09-01
IL244834A0 (en) 2016-05-31
KR102570322B1 (ko) 2023-08-23

Similar Documents

Publication Publication Date Title
CR20160188A (es) Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido
PE20131063A1 (es) Composicion acuosa que contiene bromhexina
ECSP16084431A (es) Composiciones estables de yodo no en complejo y métodos de uso
PE20151426A1 (es) Solucion para preservar conductos vasculares
CL2015000574A1 (es) Formulaciones acuosas estables de adalimumab.
PE20161172A1 (es) Complejos de cobre-amonio y de cobre-zinc-amonio solubilizados con acidos, composiciones, preparaciones, metodos y usos
CR20140053A (es) Formulaciones de ácido desoxicólico y sales del mismo
CL2012003488A1 (es) Formulación intravenosa que comprende una solución acuosa de sulfobutil-eter-beta-ciclodextrina y amiodarona o una sal en proporción entre 2,7: 1 a 7:1; metodo de preparación; un artículo manufacturado, util en arritmias.
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
EA201400535A1 (ru) Индивидуальная композиция для очищения
BR112015026077A2 (pt) barra de sabão e método de redução de bactérias gram positivas em pele humana
WO2014160872A3 (en) Throat gargle tablet and method of use thereof
EA201490127A1 (ru) Офтальмологический раствор, содержащий гиалуроновую кислоту или ее соль и пропиленгликоль
EA201791191A1 (ru) Водные фармацевтические композиции для местного применения в ротовой полости, содержащие флурбипрофен и декспантенол
RU2010129784A (ru) Способ приготовления противотуберкулезного лекарственного препарата
TH172594A (th) วิธีแก้ปัญหาสำหรับการเพิ่มเสถียรภาพและอายุการเก็บบนชั้นของสารละลาย การเก็บถนอมเนื้อเยื่อและอวัยวะ
TH161382A (th) องค์ประกอบที่เป็นน้ำที่ประกอบด้วยกรด 2-อะมิโน-3-(4-โบรโมเบนโซอิล) ฟีนิลอะซีติก
AR094404A1 (es) Tratamiento microbicida para frutas y verduras comestibles
TH168841A (th) องค์ประกอบที่ใช้สำหรับช่องปากและสารลดภาวะเครียดออกซิเดชัน
RU2013153124A (ru) Сироп, обладающий противовирусным действием
TH162256A (th) ตัวยับยั้งการตายของเซลล์เนื้อเยื่อบุผิวของกระจกตาซึ่งมีฟลาวินแอดีนีนไดนิวคลีโอไทด์หรือเกลือของสิ่งเหล่านี้ในฐานะเป็นสารออกฤทธิ์
UA88421U (ru) Фармацевтическая композиция "фузипан-дерма" для лечения угревой болезни i-ii стадий
MX353555B (es) Composiciones acuosas que contienen la sal de potasio del acido (s)-(+)-abscisico.
EA201201219A1 (ru) Фармацевтический состав, обладающий метаболическим, противокатарактным, ретинопротекторным действием (варианты)
FR3010901B1 (fr) Principe actif cosmetique pour lutter contre la perte de volume des tissus notamment du visage